Modeling synaptogenesis in schizophrenia and autism using human iPSC derived neurons

Molecular and Cellular Neuroscience

Volumn 73, Issue , 2016, Pages 52-62

  Habela, Christa W ^a   Song, Hongjun ^a   Ming, Guo li ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glutamatergic neurons; IPSCs; Neural development; Neurodevelopmental disorders; Synapses

Indexed keywords

AUTISM; DISEASE PREDISPOSITION; GLUTAMATERGIC SYNAPSE; HUMAN; INDUCED PLURIPOTENT STEM CELL DERIVED NEURON; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SYNAPTOGENESIS; BIOLOGICAL MODEL; CELL CULTURE TECHNIQUE; CYTOLOGY; GENETICS; INDUCED PLURIPOTENT STEM CELL; METABOLISM; PATHOLOGY; PROCEDURES; SYNAPSE;

AUTISTIC DISORDER; CELL CULTURE TECHNIQUES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MODELS, BIOLOGICAL; NEUROGENESIS; NEURONS; SCHIZOPHRENIA; SYNAPSES;

EID: 84952890155     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2015.12.002     Document Type: Review

References (125)

1. Aasen T., Raya A., Barrero M.J., Garreta E., Consiglio A., Gonzalez F., Vassena R., Bilic J., Pekarik V., Tiscornia G., Edel M., Boue S., Izpisua Belmonte J.C. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 2008, 26:1276-1284.
2. Alexander-Bloch A.F., Vertes P.E., Stidd R., Lalonde F., Clasen L., Rapoport J., Giedd J., Bullmore E.T., Gogtay N. The anatomical distance of functional connections predicts brain network topology in health and schizophrenia. Cereb. Cortex 2013, 23:127-138.
3. Ameis S.H., Catani M. Altered white matter connectivity as a neural substrate for social impairment in autism spectrum disorder. Cortex 2015, 62:158-181.
4. Ananiev G., Williams E.C., Li H., Chang Q. Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model. PLoS One 2011, 6.
5. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
6. Belichenko P.V., Oldfors A., Hagberg B., Dahlstrom A. Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. Neuroreport 1994, 5:1509-1513.
7. Belichenko P.V., Wright E.E., Belichenko N.P., Masliah E., Li H.H., Mobley W.C., Francke U. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. J. Comp. Neurol. 2009, 514:240-258.
8. Bernardinelli Y., Nikonenko I., Muller D. Structural plasticity: mechanisms and contribution to developmental psychiatric disorders. Front. Neuroanat. 2014, 8:123.
9. Bond A.M., Ming G.L., Song H. Adult mammalian neural stem cells and neurogenesis: five decades later. Cell Stem Cell 2015, 17:385-395.
10. Brennand K.J., Simone A., Jou J., Gelboin-Burkhart C., Tran N., Sangar S., Li Y., Mu Y., Chen G., Yu D., McCarthy S., Sebat J., Gage F.H. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011, 473:221-225.
11. Broadbelt K., Byne W., Jones L.B. Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex. Schizophr. Res. 2002, 58:75-81.
12. Brown S. Excess mortality of schizophrenia. A meta-analysis. Br. J. Psychiatry 1997, 171:502-508.
13. Brown M.E., Rondon E., Rajesh D., Mack A., Lewis R., Feng X., Zitur L.J., Learish R.D., Nuwaysir E.F. Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes. PLoS One 2010, 5.
14. Browning M.D., Dudek E.M., Rapier J.L., Leonard S., Freedman R. Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol. Psychiatry 1993, 34:529-535.
15. Cannon T.D., Thompson P.M., van Erp T.G., Toga A.W., Poutanen V.P., Huttunen M., Lonnqvist J., Standerskjold-Nordenstam C.G., Narr K.L., Khaledy M., Zoumalan C.I., Dail R., Kaprio J. Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:3228-3233.
16. Carbon M., Correll C.U. Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia. CNS Spectr. 2014, 19(Suppl. 1):38-52. (quiz 35-7, 53).
17. Caroni P., Donato F., Muller D. Structural plasticity upon learning: regulation and functions. Nat. Rev. Neurosci. 2012, 13:478-490.
18. Carper R.A., Courchesne E. Localized enlargement of the frontal cortex in early autism. Biol. Psychiatry 2005, 57:126-133.
19. Chambers J.S., Thomas D., Saland L., Neve R.L., Perrone-Bizzozero N.I. Growth-associated protein 43 (GAP-43) and synaptophysin alterations in the dentate gyrus of patients with schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2005, 29:283-290.
20. Cheung A.Y., Horvath L.M., Grafodatskaya D., Pasceri P., Weksberg R., Hotta A., Carrel L., Ellis J. Isolation of MECP2-null Rett syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum. Mol. Genet. 2011, 20:2103-2115.
21. Chiang C.H., Su Y., Wen Z., Yoritomo N., Ross C.A., Margolis R.L., Song H., Ming G.L. Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol. Psychiatry 2011, 16:358-360.
22. Christian K.M., Song H., Ming G.L. Functions and dysfunctions of adult hippocampal neurogenesis. Annu. Rev. Neurosci. 2014, 37:243-262.
23. Comery T.A., Harris J.B., Willems P.J., Oostra B.A., Irwin S.A., Weiler I.J., Greenough W.T. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:5401-5404.
24. Courchesne E., Karns C.M., Davis H.R., Ziccardi R., Carper R.A., Tigue Z.D., Chisum H.J., Moses P., Pierce K., Lord C., Lincoln A.J., Pizzo S., Schreibman L., Haas R.H., Akshoomoff N.A., Courchesne R.Y. Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology 2001, 57:245-254.
25. Courchesne E., Campbell K., Solso S. Brain growth across the life span in autism: age-specific changes in anatomical pathology. Brain Res. 2011, 1380:138-145.
26. de Bartolomeis A., Latte G., Tomasetti C., Iasevoli F. Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches. Mol. Neurobiol. 2014, 49:484-511.
27. De Rubeis S., He X., Goldberg A.P., Poultney C.S., Samocha K., Cicek A.E., Kou Y., Liu L., Fromer M., Walker S., Singh T., Klei L., Kosmicki J., Shih-Chen F., Aleksic B., Biscaldi M., Bolton P.F., Brownfeld J.M., Cai J., Campbell N.G., Carracedo A., Chahrour M.H., Chiocchetti A.G., Coon H., Crawford E.L., Curran S.R., Dawson G., Duketis E., Fernandez B.A., Gallagher L., Geller E., Guter S.J., Hill R.S., Ionita-Laza J., Jimenz Gonzalez P., Kilpinen H., Klauck S.M., Kolevzon A., Lee I., Lei I., Lei J., Lehtimaki T., Lin C.F., Ma'ayan A., Marshall C.R., McInnes A.L., Neale B., Owen M.J., Ozaki N., Parellada M., Parr J.R., Purcell S., Puura K., Rajagopalan D., Rehnstrom K., Reichenberg A., Sabo A., Sachse M., Sanders S.J., Schafer C., Schulte-Ruther M., Skuse D., Stevens C., Szatmari P., Tammimies K., Valladares O., Voran A., Li-San W., Weiss L.A., Willsey A.J., Yu T.W., Yuen R.K., Study D.D.D., UK10K Consortium, Cook E.H., Freitag C.M., Gill M., Hultman C.M., Lehner T., Palotie A., Schellenberg G.D., Sklar P., State M.W., Sutcliffe J.S., Walsh C.A., Scherer S.W., Zwick M.E., Barett J.C., Cutler D.J., Roeder K., Devlin B., Daly M.J., Buxbaum J.D. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 2014, 515:209-215. Homozygosity Mapping Collaborative for Autism.
28. Doers M.E., Musser M.T., Nichol R., Berndt E.R., Baker M., Gomez T.M., Zhang S.C., Abbeduto L., Bhattacharyya A. iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth. Stem Cells Dev. 2014, 23:1777-1787.
29. DSM-5.5th Edition.Washington, DC: American Psychiatric Association; American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatric Association, Washington, DC. fifth ed.
30. Duan X., Chang J.H., Ge S., Faulkner R.L., Kim J.Y., Kitabatake Y., Liu X.B., Yang C.H., Jordan J.D., Ma D.K., Liu C.Y., Ganesan S., Cheng H.J., Ming G.L., Lu B., Song H. Disrupted-in-schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell 2007, 130:1146-1158.
31. Ecker C., Bookheimer S.Y., Murphy D.G. Neuroimaging in autism spectrum disorder: brain structure and function across the lifespan. Lancet Neurol. 2015, 14:1121-1134.
32. Faigle R., Song H. Signaling mechanisms regulating adult neural stem cells and neurogenesis. Biochim. Biophys. Acta 2013, 1830:2435-2448.
33. Faludi G., Mirnics K. Synaptic changes in the brain of subjects with schizophrenia. Int. J. Dev. Neurosci. 2011, 29:305-309.
34. Foster N.E., Doyle-Thomas K.A., Tryfon A., Ouimet T., Anagnostou E., Evans A.C., Zwaigenbaum L., Lerch J.P., Lewis J.D., Hyde K.L., NeuroDevNet ASD imaging group Structural gray matter differences during childhood development in autism spectrum disorder: a multimetric approach. Pediatr. Neurol. 2015, 53:350-359.
35. Frankle W.G., Lerma J., Laruelle M. The synaptic hypothesis of schizophrenia. Neuron 2003, 39:205-216.
36. Fromer M., Pocklington A.J., Kavanagh D.H., Williams H.J., Dwyer S., Gormley P., Georgieva L., Rees E., Palta P., Ruderfer D.M., Carrera N., Humphreys I., Johnson J.S., Roussos P., Barker D.D., E Banks, Milanova V., Grant S.G., Hannon E., Rose S.A., Chambert K., Mahajan M., Scolnick E.M., Moran J.L., Kirov G., Palotie A., McCarroll S.A., Holmans P., Sklar P., Owen M.J., Purcell S.M., O'Donovan M.C. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014, 506:179-184.
37. Fukuda T., Itoh M., Ichikawa T., Washiyama K., Goto Y. Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. J. Neuropathol. Exp. Neurol. 2005, 64:537-544.
38. Garey L.J., Ong W.Y., Patel T.S., Kanani M., Davis A., Mortimer A.M., Barnes T.R., Hirsch S.R. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J. Neurol. Neurosurg. Psychiatry 1998, 65:446-453.
39. Germain N.D., Chen P.-F., Plocik A.M., Glatt-Deeley H., Brown J., Fink J.J., Bolduc K.A., Robinson T.M., Levine E.S., Reiter L.T., Graveley B.R., Lalande M., Chamberlain S.J. Gene expression analysis of human induced pluripotent stem cell-derived neurons carrying copy number variants of chromosome 15q11-q13.1. Molecular Autism 2014, 5(44). 10.1186/2040-2392-5-44.
40. Glantz L.A., Lewis D.A. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch. Gen. Psychiatry 1997, 54:943-952.
41. Glantz L.A., Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 2000, 57:65-73.
42. Greenstein D., Lerch J., Shaw P., Clasen L., Giedd J., Gochman P., Rapoport J., Gogtay N. Childhood onset schizophrenia: cortical brain abnormalities as young adults. J. Child Psychol. Psychiatry 2006, 47:1003-1012.
43. Griesi-Oliveira K., Acab A., Gupta A.R., Sunaga D.Y., Chailangkarn T., Nicol X., Nunez Y., Walker M.F., Murdoch J.D., Sanders S.J., Fernandez T.V., Ji W., Lifton R.P., Vadasz E., Dietrich A., Pradhan D., Song H., Ming G.L., Gu X., Haddad G., Marchetto M.C., Spitzer N., Passos-Bueno M.R., State M.W., Muotri A.R. Modeling Non-syndromic Autism and the Impact of TRPC6 Disruption in Human Neurons 2014, Mol. Psychiatry.
44. Harrison P.J., Law A.J. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol. Psychiatry 2006, 60:132-140.
45. Hartley B.J., Tran N., Ladran I., Reggio K., Brennand K.J. Dopaminergic differentiation of schizophrenia hiPSCs. Mol. Psychiatry 2015, 20:549-550.
46. Hashimoto-Torii K., Torii M., Fujimoto M., Nakai A., El Fatimy R., Mezger V., Ju M.J., Ishii S., Chao S.H., Brennand K.J., Gage F.H., Rakic P. Roles of heat shock factor 1 in neuronal response to fetal environmental risks and its relevance to brain disorders. Neuron 2014, 82:560-572.
47. Hook V., Brennand K.J., Kim Y., Toneff T., Funkelstein L., Lee K.C., Ziegler M., Gage F.H. Human iPSC neurons display activity-dependent neurotransmitter secretion: aberrant catecholamine levels in schizophrenia neurons. Stem Cell Rep. 2014, 3:531-538.
48. Hu W., MacDonald M.L., Elswick D.E., Sweet R.A. The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies. Ann. N. Y. Acad. Sci. 2015, 1338:38-57.
49. Huganir R.L., Nicoll R.A. AMPARs and synaptic plasticity: the last 25 years. Neuron 2013, 80:704-717.
50. Huguet G., Ey E., Bourgeron T. The genetic landscapes of autism spectrum disorders. Annu. Rev. Genomics Hum. Genet. 2013, 14:191-213.
51. Hutsler J.J., Zhang H. Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res. 2010, 1309:83-94.
52. Huttenlocher P.R. Synaptic density in human frontal cortex - developmental changes and effects of aging. Brain Res. 1979, 163:195-205.
53. Irwin S.A., Patel B., Idupulapati M., Harris J.B., Crisostomo R.A., Larsen B.P., Kooy F., Willems P.J., Cras P., Kozlowski P.B., Swain R.A., Weiler I.J., Greenough W.T. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am. J. Med. Genet. 2001, 98:161-167.
54. Ishii S., Hashimoto-Torii K. Impact of prenatal environmental stress on cortical development. Front. Cell. Neurosci. 2015, 9:207.
55. Javitt D.C. Glycine transport inhibitors and the treatment of schizophrenia. Biol. Psychiatry 2008, 63:6-8.
56. Jones C.A., Watson D.J., Fone K.C. Animal models of schizophrenia. Br. J. Pharmacol. 2011, 164:1162-1194.
57. Juopperi T.A., Song H., Ming G.L. Modeling neurological diseases using patient-derived induced pluripotent stem cells. Future Neurol. 2011, 6:363-373.
58. Just M.A., Keller T.A., Malave V.L., Kana R.K., Varma S. Autism as a neural systems disorder: a theory of frontal-posterior underconnectivity. Neurosci. Biobehav. Rev. 2012, 36:1292-1313.
59. Karson C.N., Mrak R.E., Schluterman K.O., Sturner W.Q., Sheng J.G., Griffin W.S. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'. Mol. Psychiatry 1999, 4:39-45.
60. Kolluri N., Sun Z., Sampson A.R., Lewis D.A. Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. Am. J. Psychiatry 2005, 162:1200-1202.
61. Konopaske G.T., Lange N., Coyle J.T., Benes F.M. Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder. JAMA Psychiatry 2014, 71:1323-1331.
62. Kumar R.A., Christian S.L. Genetics of autism spectrum disorders. Curr. Neurol. Neurosci. Rep. 2009, 9:188-197.
63. Lai M.C., Lombardo M.V., Baron-Cohen S. Autism. Lancet 2014, 383:896-910.
64. Lange N., Travers B.G., Bigler E.D., Prigge M.B., Froehlich A.L., Nielsen J.A., Cariello A.N., Zielinski B.A., Anderson J.S., Fletcher P.T., Alexander A.A., Lainhart J.E. Longitudinal volumetric brain changes in autism spectrum disorder ages 6-35 years. Autism Res. 2015, 8:82-93.
65. Lau C.G., Zukin R.S. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat. Rev. Neurosci. 2007, 8:413-426.
66. Leucht S., Corves C., Arbter D., Engel R.R., Li C., Davis J.M. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009, 373:31-41.
67. Levy S.E., Mandell D.S., Schultz R.T. Autism. Lancet 2009, 374:1627-1638.
68. Lisman J.E., Coyle J.T., Green R.W., Javitt D.C., Benes F.M., Heckers S., Grace A.A. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 2008, 31:234-242.
69. Liu Y., Liang M., Zhou Y., He Y., Hao Y., Song M., Yu C., Liu H., Liu Z., Jiang T. Disrupted small-world networks in schizophrenia. Brain 2008, 131:945-961.
70. Loh Y.H., Hartung O., Li H., Guo C., Sahalie J.M., Manos P.D., Urbach A., Heffner G.C., Grskovic M., Vigneault F., Lensch M.W., Park I.H., Agarwal S., Church G.M., Collins J.J., Irion S., Daley G.Q. Reprogramming of T cells from human peripheral blood. Cell Stem Cell 2010, 7:15-19.
71. Lowry W.E., Richter L., Yachechko R., Pyle A.D., Tchieu J., Sridharan R., Clark A.T., Plath K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:2883-2888.
72. Marchetto M.C., Carromeu C., Acab A., Yu D., Yeo G.W., Mu Y., Chen G., Gage F.H., Muotri A.R. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010, 143:527-539.
73. Mariani J., Simonini M.V., Palejev D., Tomasini L., Coppola G., Szekely A.M., Horvath T.L., Vaccarino F.M. Modeling human cortical development in vitro using induced pluripotent stem cells. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:12770-12775.
74. Mariani J., Coppola G., Zhang P., Abyzov A., Provini L., Tomasini L., Amenduni M., Szekely A., Palejev D., Wilson M., Gerstein M., Grigorenko E.L., Chawarska K., Pelphrey K.A., Howe J.R., Vaccarino F.M. FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders. Cell 2015, 162:375-390.
75. Melton C., Judson R.L., Blelloch R. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 2010, 463:621-626.
76. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000, 28:53-67.
77. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., Levitt P. Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci. 2001, 24:479-486.
78. Mistry M., Pavlidis P. A cross-laboratory comparison of expression profiling data from normal human postmortem brain. Neuroscience 2010, 167:384-395.
79. Mistry M., Gillis J., Pavlidis P. Meta-analysis of gene coexpression networks in the post-mortem prefrontal cortex of patients with schizophrenia and unaffected controls. BMC Neurosci. 2013, 14. (105-2202-14-105).
80. Miyamoto S., Miyake N., Jarskog L.F., Fleischhacker W.W., Lieberman J.A. Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents. Mol. Psychiatry 2012, 17:1206-1227.
81. O'Tuathaigh C.M., Waddington J.L. Closing the Translational gap Between Mutant Mouse Models and the Clinical Reality of Psychotic Illness 2015, Neurosci. Biobehav, Rev.
82. Ozonoff S., Iosif A.M., Baguio F., Cook I.C., Hill M.M., Hutman T., Rogers S.J., Rozga A., Sangha S., Sigman M., Steinfeld M.B., Young G.S. A prospective study of the emergence of early behavioral signs of autism. J. Am. Acad. Child Adolesc. Psychiatry 2010, 49:256-266. (e1-2).
83. Pedrosa E., Sandler V., Shah A., Carroll R., Chang C., Rockowitz S., Guo X., Zheng D., Lachman H.M. Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells. J. Neurogenet. 2011, 25:88-103.
84. Petanjek Z., Judas M., Simic G., Rasin M.R., Uylings H.B., Rakic P., Kostovic I. Extraordinary neoteny of synaptic spines in the human prefrontal cortex. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:13281-13286.
85. Pinto D., Delaby E., Merico D., Barbosa M., Merikangas A., Klei L., Thiruvahindrapuram B., Xu X., Ziman R., Wang Z., Vorstman J.A., Thompson A., Regan R., Pilorge M., Pellecchia G., Pagnamenta A.T., Oliveira B., Marshall C.R., Magalhaes T.R., Lowe J.K., Howe J.L., Griswold A.J., Gilbert J., Duketis E., Dombroski B.A., De Jonge M.V., Cuccaro M., Crawford E.L., Correia C.T., Conroy J., Conceicao I.C., Chiocchetti A.G., Casey J.P., Cai G., Cabrol C., Bolshakova N., Bacchelli E., Anney R., Gallinger S., Cotterchio M., Casey G., Zwaigenbaum L., Wittemeyer K., Wing K., Wallace S., van Engeland H., Tryfon A., Thomson S., Soorya L., Roge B., Roberts W., Poustka F., Mouga S., Minshew N., McInnes L.A., McGrew S.G., Lord C., Leboyer M., Le Couteur A.S., Kolevzon A., Jimenez Gonzalez P., Jacob S., Holt R., Guter S., Green J., Green A., Gillberg C., Fernandez B.A., Duque F., Delorme R., Dawson G., Chaste P., Cafe C., Brennan S., Bourgeron T., Bolton P.F., Bolte S., Bernier R., Baird G., Bailey A.J., Anagnostou E., Almeida J., Wijsman E.M., Vieland V.J., Vicente A.M., Schellenberg G.D., Pericak-Vance M., Paterson A.D., Parr J.R., Oliveira G., Nurnberger J.I., Monaco A.P., Maestrini E., Klauck S.M., Hakonarson H., Haines J.L., Geschwind D.H., Freitag C.M., Folstein S.E., Ennis S., Coon H., Battaglia A., Szatmari P., Sutcliffe J.S., Hallmayer J., Gill M., Cook E.H., Buxbaum J.D., Devlin B., Gallagher L., Betancur C., Scherer S.W. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am. J. Hum. Genet. 2014, 94:677-694.
86. Pocklington A.J., O'Donovan M., Owen M.J. The synapse in schizophrenia. Eur. J. Neurosci. 2014, 39:1059-1067.
87. Rapoport J.L., Giedd J.N., Gogtay N. Neurodevelopmental model of schizophrenia: update 2012. Mol. Psychiatry 2012, 17:1228-1238.
88. Robicsek O., Karry R., Petit I., Salman-Kesner N., Muller F.J., Klein E., Aberdam D., Ben-Shachar D. Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients. Mol. Psychiatry 2013, 18:1067-1076.
89. Rosso S.B., Inestrosa N.C. WNT signaling in neuronal maturation and synaptogenesis. Front. Cell. Neurosci. 2013, 7:103.
90. Sachs N.A., Sawa A., Holmes S.E., Ross C.A., DeLisi L.E., Margolis R.L. A frameshift mutation in disrupted in schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder. Mol. Psychiatry 2005, 10:758-764.
91. Saha S., Chant D., Welham J., McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005, 2.
92. Sandin S., Lichtenstein P., Kuja-Halkola R., Larsson H., Hultman C.M., Reichenberg A. The familial risk of autism. JAMA 2014, 311:1770-1777.
93. Schizophrenia Working Group of the Psychiatric Genomics Consortium Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014, 511:421-427.
94. Schumann C.M., Bloss C.S., Barnes C.C., Wideman G.M., Carper R.A., Akshoomoff N., Pierce K., Hagler D., Schork N., Lord C., Courchesne E. Longitudinal magnetic resonance imaging study of cortical development through early childhood in autism. J. Neurosci. 2010, 30:4419-4427.
95. Sebat J., Levy D.L., McCarthy S.E. Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet. 2009, 25:528-535.
96. Seki T., Yuasa S., Oda M., Egashira T., Yae K., Kusumoto D., Nakata H., Tohyama S., Hashimoto H., Kodaira M., Okada Y., Seimiya H., Fusaki N., Hasegawa M., Fukuda K. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 2010, 7:11-14.
97. Shcheglovitov A., Shcheglovitova O., Yazawa M., Portmann T., Shu R., Sebastiano V., Krawisz A., Froehlich W., Bernstein J.A., Hallmayer J.F., Dolmetsch R.E. SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature 2013, 503:267-271.
98. Shepherd J.D., Bear M.F. New views of Arc, a master regulator of synaptic plasticity. Nat. Neurosci. 2011, 14:279-284.
99. Sheridan S.D., Theriault K.M., Reis S.A., Zhou F., Madison J.M., Daheron L., Loring J.F., Haggarty S.J. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS One 2011, 6.
100. Soares D.C., Carlyle B.C., Bradshaw N.J., Porteous D.J. DISC1: structure, function, and therapeutic potential for major mental illness. ACS Chem. Neurosci. 2011, 2:609-632.
101. Spooren W., Lindemann L., Ghosh A., Santarelli L. Synapse dysfunction in autism: a molecular medicine approach to drug discovery in neurodevelopmental disorders. Trends Pharmacol. Sci. 2012, 33:669-684.
102. Staerk J., Dawlaty M.M., Gao Q., Maetzel D., Hanna J., Sommer C.A., Mostoslavsky G., Jaenisch R. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 2010, 7:20-24.
103. Sudhof T.C., Malenka R.C. Understanding synapses: past, present, and future. Neuron 2008, 60:469-476.
104. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 2003, 60:1187-1192.
105. Sweet R.A., Henteleff R.A., Zhang W., Sampson A.R., Lewis D.A. Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology 2009, 34:374-389.
106. Takahashi K., Okita K., Nakagawa M., Yamanaka S. Induction of pluripotent stem cells from fibroblast cultures. Nat. Protoc. 2007, 2:3081-3089.
107. Tandon R., Gaebel W., Barch D.M., Bustillo J., Gur R.E., Heckers S., Malaspina D., Owen M.J., Schultz S., Tsuang M., Van Os J., Carpenter W. Definition and description of schizophrenia in the DSM-5. Schizophr. Res. 2013, 150:3-10.
108. Tang G., Gudsnuk K., Kuo S.H., Cotrina M.L., Rosoklija G., Sosunov A., Sonders M.S., Kanter E., Castagna C., Yamamoto A., Yue Z., Arancio O., Peterson B.S., Champagne F., Dwork A.J., Goldman J., Sulzer D. Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron 2014, 83:1131-1143.
109. Thomson P.A., Malavasi E.L., Grunewald E., Soares D.C., Borkowska M., Millar J.K. DISC1 genetics, biology and psychiatric illness. Front. Biol. 2013, 8:1-31.
110. Tian Y., Voineagu I., Pasca S.P., Won H., Chandran V., Horvath S., Dolmetsch R.E., Geschwind D.H. Alteration in basal and depolarization induced transcriptional network in iPSC derived neurons from Timothy syndrome. Genome Med. 2014, 6. (75-014-0075-5. eCollection 20140.
111. Topol A., Zhu S., Tran N., Simone A., Fang G., Brennand K.J. Altered WNT Signaling in Human Induced Pluripotent Stem Cell Neural Progenitor Cells Derived from Four Schizophrenia Patients 2015, Biol, Psychiatry.
112. Tropea D., Giacometti E., Wilson N.R., Beard C., McCurry C., Fu D.D., Flannery R., Jaenisch R., Sur M. Partial reversal of rett syndrome-like symptoms in MeCP2 mutant mice. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2029-2034.
113. Tsai G., Coyle J.T. Glutamatergic mechanisms in schizophrenia. Annu. Rev. Pharmacol. Toxicol. 2002, 42:165-179.
114. Ugolini G. Use of rabies virus as a transneuronal tracer of neuronal connections: implications for the understanding of rabies pathogenesis. Dev. Biol. (Basel) 2008, 131:493-506.
115. Volk L., Chiu S.L., Sharma K., Huganir R.L. Glutamate synapses in human cognitive disorders. Annu. Rev. Neurosci. 2015, 38:127-149.
116. Wallace G.L., Dankner N., Kenworthy L., Giedd J.N., Martin A. Age-related temporal and parietal cortical thinning in autism spectrum disorders. Brain 2010, 133:3745-3754.
117. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., Nord A.S., Kusenda M., Malhotra D., Bhandari A., Stray S.M., Rippey C.F., Roccanova P., Makarov V., Lakshmi B., Findling R.L., Sikich L., Stromberg T., Merriman B., Gogtay N., Butler P., Eckstrand K., Noory L., Gochman P., Long R., Chen Z., Davis S., Baker C., Eichler E.E., Meltzer P.S., Nelson S.F., Singleton A.B., Lee M.K., Rapoport J.L., King M.C., Sebat J. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320:539-543.
118. Wen Z., Nguyen H.N., Guo Z., Lalli M.A., Wang X., Su Y., Kim N.S., Yoon K.J., Shin J., Zhang C., Makri G., Nauen D., Yu H., Guzman E., Chiang C.H., Yoritomo N., Kaibuchi K., Zou J., Christian K.M., Cheng L., Ross C.A., Margolis R.L., Chen G., Kosik K.S., Song H., Ming G.L. Synaptic dysregulation in a human iPS cell model of mental disorders. Nature 2014, 515:414-418.
119. Yamanaka S., Takahashi K. Induction of pluripotent stem cells from mouse fibroblast cultures. Tanpakushitsu Kakusan Koso 2006, 51:2346-2351.
120. Yoon K.J., Nguyen H.N., Ursini G., Zhang F., Kim N.S., Wen Z., Makri G., Nauen D., Shin J.H., Park Y., Chung R., Pekle E., Zhang C., Towe M., Hussaini S.M., Lee Y., Rujescu D., St Clair D., Kleinman J.E., Hyde T.M., Krauss G., Christian K.M., Rapoport J.L., Weinberger D.R., Song H., Ming G.L. Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity. Cell Stem Cell 2014, 15:79-91.
121. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin I.I., Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
122. Yu D.X., Di Giorgio F.P., Yao J., Marchetto M.C., Brennand K., Wright R., Mei A., McHenry L., Lisuk D., Grasmick J.M., Silberman P., Silberman G., Jappelli R., Gage F.H. Modeling hippocampal neurogenesis using human pluripotent stem cells. Stem Cell Rep. 2014, 2:295-310.
123. Zalesky A., Fornito A., Seal M.L., Cocchi L., Westin C.F., Bullmore E.T., Egan G.F., Pantelis C. Disrupted axonal fiber connectivity in schizophrenia. Biol. Psychiatry 2011, 69:80-89.
124. Zhao D., Lin M., Chen J., Pedrosa E., Hrabovsky A., Fourcade H.M., Zheng D., Lachman H.M. MicroRNA profiling of neurons generated using induced pluripotent stem cells derived from patients with schizophrenia and schizoaffective disorder, and 22q11.2 Del. PLoS One 2015, 10.
125. Zielinski B.A., Prigge M.B., Nielsen J.A., Froehlich A.L., Abildskov T.J., Anderson J.S., Fletcher P.T., Zygmunt K.M., Travers B.G., Lange N., Alexander A.L., Bigler E.D., Lainhart J.E. Longitudinal changes in cortical thickness in autism and typical development. Brain 2014, 137:1799-1812.